Brian Taylor Slingsby - Net Worth and Insider Trading

Brian Taylor Slingsby Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian Taylor Slingsby owns 1 companies in total, including Mineralys Therapeutics Inc (MLYS) .

Click here to see the complete history of Brian Taylor Slingsby’s form 4 insider trades.

Insider Ownership Summary of Brian Taylor Slingsby

Ticker	Comapny	Transaction Date	Type of Owner
MLYS	Mineralys Therapeutics Inc	2023-02-09	director & 10 percent owner

Brian Taylor Slingsby Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brian Taylor Slingsby Ownership Network

Ownership Network List of Brian Taylor Slingsby

No Data

Ownership Network Relation of Brian Taylor Slingsby

Brian Taylor Slingsby Owned Company Details

What does Mineralys Therapeutics Inc do?

Who are the key executives at Mineralys Therapeutics Inc?

Brian Taylor Slingsby is the director & 10 percent owner of Mineralys Therapeutics Inc. Other key executives at Mineralys Therapeutics Inc include Chief Medical Officer David Malcom Rodman , director & Chief Executive Officer Jon Congleton , and CFO & Chief Bus. Off. and Secy. Adam Scott Levy .

Mineralys Therapeutics Inc (MLYS) Insider Trades Summary

Over the past 18 months, Brian Taylor Slingsby made no insider transaction in Mineralys Therapeutics Inc (MLYS). Other recent insider transactions involving Mineralys Therapeutics Inc (MLYS) include a net sale of 142,377 shares made by Jon Congleton , a net sale of 262,849 shares made by David Malcom Rodman , and a net sale of 118,329 shares made by Adam Scott Levy .

In summary, during the past 3 months, insiders sold 56,536 shares of Mineralys Therapeutics Inc (MLYS) in total and bought 0 shares, with a net sale of 56,536 shares. During the past 18 months, 1,084,305 shares of Mineralys Therapeutics Inc (MLYS) were sold and 566,305 shares were bought by its insiders, resulting in a net sale of 518,000 shares.

Mineralys Therapeutics Inc (MLYS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mineralys Therapeutics Inc Insider Transactions

No Available Data

Brian Taylor Slingsby Mailing Address

Above is the net worth, insider trading, and ownership report for Brian Taylor Slingsby. You might contact Brian Taylor Slingsby via mailing address: C/o Mineralys Therapeutics, Inc., 150 N. Radnor Chester Rd, Ste. F200, Radnor Pa 19087.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.